BioVie Inc. 8-K Filing Summary
Business Context and Reporting Period
This Form 8-K reports on the results of BioVie Inc.'s 2023 Annual Meeting of Stockholders held on November 8, 2023. The company is incorporated in Nevada and its Class A Common Stock trades on the NASDAQ under the symbol "BIVI".
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Two primary matters were submitted to a vote of security holders:
- Election of Directors: Stockholders elected all seven nominees for one-year terms. The nominees received significant support, with "For" votes ranging from approximately 24.5 million to 24.9 million. "Withhold" votes ranged from approximately 74,000 to 388,000. There were 4,528,595 broker non-votes for all director candidates.
- Approval of Auditors: Stockholders approved and ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the 2024 fiscal year. The vote was 29,275,023 "For", 180,567 "Against", and 19,155 "Abstain". There were 4,528,595 broker non-votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation that all seven director nominees were successfully elected.
- Verification that EisnerAmper LLP is the appointed auditor for the 2024 fiscal year.
- Review of the significant number of broker non-votes (4,528,595) relative to the total votes cast.